These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7624134)

  • 21. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C; Donovan J; Bhattacharya N; Stampfer M; Worland P; Slingerland J
    Oncogene; 2000 Nov; 19(47):5314-23. PubMed ID: 11103932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases.
    Wang Y; Prives C
    Nature; 1995 Jul; 376(6535):88-91. PubMed ID: 7596441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperoxia induces S-phase cell-cycle arrest and p21(Cip1/Waf1)-independent Cdk2 inhibition in human carcinoma T47D-H3 cells.
    Bilodeau JF; Faure R; Piedboeuf B; Mirault ME
    Exp Cell Res; 2000 May; 256(2):347-57. PubMed ID: 10772807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins.
    Zariwala M; Liu J; Xiong Y
    Oncogene; 1998 Nov; 17(21):2787-98. PubMed ID: 9840943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
    Liang YC; Lin-Shiau SY; Chen CF; Lin JK
    J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role for c-Abl tyrosine kinase in growth arrest response to DNA damage.
    Yuan ZM; Huang Y; Whang Y; Sawyers C; Weichselbaum R; Kharbanda S; Kufe D
    Nature; 1996 Jul; 382(6588):272-4. PubMed ID: 8717045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different mechanisms for inhibition of cell proliferation via cell cycle proteins in PC12 cells by nerve growth factor and staurosporine.
    Gollapudi L; Neet KE
    J Neurosci Res; 1997 Aug; 49(4):461-74. PubMed ID: 9285522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2.
    Morisaki H; Fujimoto A; Ando A; Nagata Y; Ikeda K; Nakanishi M
    Biochem Biophys Res Commun; 1997 Nov; 240(2):386-90. PubMed ID: 9388487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PKCeta associates with cyclin E/cdk2/p21 complex, phosphorylates p21 and inhibits cdk2 kinase in keratinocytes.
    Kashiwagi M; Ohba M; Watanabe H; Ishino K; Kasahara K; Sanai Y; Taya Y; Kuroki T
    Oncogene; 2000 Dec; 19(54):6334-41. PubMed ID: 11175348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes.
    Müller D; Bouchard C; Rudolph B; Steiner P; Stuckmann I; Saffrich R; Ansorge W; Huttner W; Eilers M
    Oncogene; 1997 Nov; 15(21):2561-76. PubMed ID: 9399644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
    Cereseto A; Washington Parks R; Rivadeneira E; Franchini G
    Oncogene; 1999 Apr; 18(15):2441-50. PubMed ID: 10229195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of the role of G1/S cell cycle mediators in cellular senescence.
    Afshari CA; Vojta PJ; Annab LA; Futreal PA; Willard TB; Barrett JC
    Exp Cell Res; 1993 Dec; 209(2):231-7. PubMed ID: 8262140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of cdk2 binding sites on the p27Kip1 cyclin-dependent kinase inhibitor.
    Kwon TK; Nordin AA
    Oncogene; 1998 Feb; 16(6):755-62. PubMed ID: 9488039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation of the myristoylated protein kinase C substrate MARCKS by the cyclin E-cyclin-dependent kinase 2 complex in vitro.
    Manenti S; Yamauchi E; Sorokine O; Knibiehler M; Van Dorsselaer A; Taniguchi H; Ducommun B; Darbon JM
    Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):775-82. PubMed ID: 10359664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of mutant p53 phosphorylation at serine 15 or serine 315 partially restores the function of wild-type p53.
    Sugikawa E; Yazaki N; Tsunoda S; Nakanishi N; Ohashi M
    Biochem Biophys Res Commun; 1999 Aug; 261(2):256-63. PubMed ID: 10425175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HsRec2/Rad51L1, a protein influencing cell cycle progression, has protein kinase activity.
    Havre PA; Rice M; Ramos R; Kmiec EB
    Exp Cell Res; 2000 Jan; 254(1):33-44. PubMed ID: 10623463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of changing the site of activating phosphorylation in CDK2 from threonine to serine.
    Kaldis P; Cheng A; Solomon MJ
    J Biol Chem; 2000 Oct; 275(42):32578-84. PubMed ID: 10931829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities.
    Fiscella M; Zambrano N; Ullrich SJ; Unger T; Lin D; Cho B; Mercer WE; Anderson CW; Appella E
    Oncogene; 1994 Nov; 9(11):3249-57. PubMed ID: 7936649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Varicella-zoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinase.
    Ye M; Duus KM; Peng J; Price DH; Grose C
    J Virol; 1999 Feb; 73(2):1320-30. PubMed ID: 9882337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.